Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
6- 10.7Regular26.10.08 01:41SCHEDULE 13GOwnership#●●●#●●●
Yarrow Bioscience, Inc.
Bellevue Group AG has filed a Schedule 13G, disclosing its beneficial ownership of Yarrow Bioscience, Inc. This filing serves to formally report the entity's significant stake in the company.…more
$19.02-1.19%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.17After-hours26.09.18 05:57SCHEDULE 13GOwnership
Yarrow Bioscience, Inc.
Multiple reporting entities, including Invus Public Equities, L.P., have filed a Schedule 13G regarding their ownership of Yarrow Bioscience, Inc. securities. The filing confirms that various investment entities represented by Raymond Debbane are acting as a joint group to manage their stake.…more
$19.02-1.19%vs prev closeView filingShare - 9.14After-hours26.09.15 05:018-KKey event
Yarrow Bioscience, Inc.
Yarrow Bioscience conducted a public offering of 5,769,231 shares of common stock at a price of $26.00 per share pursuant to an underwriting agreement dated September 10, 2026. The underwriters fully exercised their option to purchase an additional 865,384 shares, resulting in a total issuance of 6,634,615 shares and expected net proceeds of approximately $161.8 million.…more
$19.02-1.19%vs prev closeView filingShare
5 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.11Overnight26.09.11 15:44Bullish#●●●#●●●
Yarrow Bioscience Prices $150M Public Offering at $26 Per Share
Yarrow Bioscience has priced a $150 million underwritten public offering of its shares at $26.00 each. This issuance is expected to result in shareholder dilution, which may negatively impact the stock price.…more
$19.02-1.19%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 9.10After-hours26.09.11 05:03
●●●●●●●● ●●●●● ●●●●●●
Yarrow Bioscience has commenced an underwritten public offering of common stock and pre-funded warrants to fund its pipeline and corporate operations. Investors should be aware of the potential dilution resulting from this capital raise.…more
$19.02-1.19%vs prev closeShareBenzinga
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report